Article Sidebar
Main Article Content
Prognostic Value of Long Non-Coding RNAs GUSB Pseudogene 11 in Colorectal Cancer and Its Regulatory Effect on Tumor Progression
Main Article Content
Abstract
Background/Aims: Colorectal cancer (CRC) is the third most common cancer, and its progression to advanced diagnosis leads to a dismal prognosis. The long non-coding RNA (lncRNA) GUSB Pseudogene 11 (GUSBP11) can act in a variety of cancers. Nevertheless, the potential mechanism of GUSBP11 in CRC has not been reported. The purpose of this study is to investigate the relationship between the role of GUSBP11 expression in CRC progression as well as prognosis.
Materials and Methods: Two hundred and fifty-nine CRC patients were recruited. Expression levels of GUSBP11 and downstream target genes in CRC cell lines were evaluated by quantitative reverse transcription polymerase chain reaction. The influence of clinical characteristics and GUSBP11 on prognosis was evaluated by the proportional hazards model. Cell-Counting-Kit-8 and transwell assays were conducted for detection of CRC cell proliferation, migration, and invasion. Dual luciferase and correlation analyses were used to validate GUSBP11 with predicted genes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed to analyze downstream gene function and signaling pathways.
Results: The expression of GUSBP11 was upregulated in CRC and relevant to the deterioration of prognosis. The CRC cell proliferation, migration, and invasion were inhibited by GUSBP11 silencing. miR-605-3p was the downstream target gene of GUSBP11, and its expression is negatively regulated by GUSBP11.
Conclusion: Taken together, this study highlights that the inhibition of miR-605-3p by GUSBP11 to regulate the downstream signaling pathway leads to prognostic malignancy and promotes tumor growth in CRC.
Cite this article as: Hu J, Fan J, Qu S, et al. Prognostic value of lncRNA GUSBP11 in colorectal cancer and its regulatory effect on tumor progression. Turk J Gastroenterol. Published online May 20, 2025. doi 10.5152/tjg.2025.24450.
Article Details
References
1. Yao H, Sun C, Wang C, et al. The double-edged sword property of mesenchymal stem cell-derived exosomal microRNAs in colorectal cancer. Turk J Gastroenterol. 2024;35(10):755-762. [CrossRef]
2. Housini M, Dariya B, Ahmed N, et al. Colorectal cancer: genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials. Gene. 2024;892:147857. [CrossRef]
3. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254. [CrossRef]
4. Toth JF, 3rd, Trivedi M, Gupta S. Screening for colorectal cancer: the role of clinical laboratories. Clin Chem. 2024;70(1):150-164. [CrossRef]
5. Wang J, Zhu S, Meng N, He Y, Lu R, Yan GR. ncRNA-encoded peptides or proteins and cancer. Mol Ther. 2019;27(10):1718-1725. [CrossRef]
6. Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106-116. [CrossRef]
7. Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358-369. [CrossRef]
8. Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38(16):5366-5383. [CrossRef]
9. Yang S, Gou J, Wang P, Luo L, Wei D. The lncRNA GUSB pseudogene 11 (GUSBP11) promotes the tumor growth and metastasis in lung adenocarcinoma. Altern Ther Health Med. 2024;30(5):256-263.
10. Ye G, Chen Y. LncRNA FAM30A predicts adverse prognosis and regulates cellular processes in colorectal cancer via modulating miR21-3p. Turk J Gastroenterol. 2024;35(7):532-538. [CrossRef]
11. Zheng R, Liang J, Lu J, et al. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis. Gastric Cancer. 2019;22(4):731-741. [CrossRef]
12. Cao W, Liu JN, Liu Z, et al. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma. Oral Oncol. 2017;65:94-101. [CrossRef]
13. Wu G, Sun P, Qin C. GUSBP11 inhibited the progression of triple negative breast cancer via targeting the miR-579-3p/SPNS2 axis. Cell J. 2022;24(5):230-238. [CrossRef]
14. Zhang M, Yang L, Hou L, Tang X. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. Bioengineered. 2021;12(2):9239-9250. [CrossRef]
15. Zhang Q, Wang XQ, Wang J, et al. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients. Oncotarget. 2015;6(17):15095-15110. [CrossRef]
16. Fang G, Xu D, Zhang T, et al. Effects of hsa_circ_0074854 on colorectal cancer progression, construction of a circRNA-miRNA-mRNA network, and analysis of immune infiltration. J Cancer Res Clin Oncol. 2023;149(17):15439-15456. [CrossRef]
17. Xia T, Liao Q, Jiang X, et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2014;4:6088. [CrossRef]
18. Hu YL, Feng Y, Chen YY, et al. SNHG16/miR-605-3p/TRAF6/NF-kappaB feedback loop regulates hepatocellular carcinoma metastasis. J Cell Mol Med. 2020;24(13):7637-7651. [CrossRef]
19. Wang Q, Hao X, Xu G, Lv T. Downregulated KIF3B induced by miR-605-3p inhibits the progression of colon cancer via inactivating Wnt/beta-catenin. J Oncol. 2021;2021:5046981. [CrossRef]
20. Hirono T, Jingushi K, Nagata T, et al. MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2. Sci Rep. 2019;9(1):6956. [CrossRef]
21. He Z, Dang J, Song A, Cui X, Ma Z, Zhang Z. NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo. J Cell Physiol. 2019;234(11):19582-19591. [CrossRef]
22. Wang H. MicroRNAs and apoptosis in colorectal cancer. Int J Mol Sci. 2020;21(15). [CrossRef]
23. Galas A, Augustyniak M, Sochacka-Tatara E. Does dietary calcium interact with dietary fiber against colorectal cancer? A case-control study in Central Europe. Nutr J. 2013;12:134. [CrossRef]
24. Morita M, Yin G, Yoshimitsu S, et al. Folate-related nutrients, genetic polymorphisms, and colorectal cancer risk: the fukuoka colorectal cancer study. Asian Pac J Cancer Prev. 2013;14(11):6249-6256. [CrossRef]
25. Calvo N, Gentili C, de Boland AR. Parathyroid hormone and the regulation of cell cycle in colon adenocarcinoma cells. Biochim Biophys Acta. 2011;1813(10):1749-1757. [CrossRef]
26. Charalampopoulos A, Charalabopoulos A, Batistatou A, et al. Parathormone and 1,25(OH)2D3 but not 25(OH)D3 serum levels, in an inverse correlation, reveal an association with advanced stages of colorectal cancer. Clin Exp Med. 2010;10(1):69-72. [CrossRef]
27. Fedirko V, Riboli E, Bueno-de-Mesquita HB, et al. Prediagnostic circulating parathyroid hormone concentration and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Cancer Epidemiol Biomarkers Prev. 2011;20(5):767-778. [CrossRef]
28. Sarkar P, Kumar S. Calcium sensing receptor modulation for cancer therapy. Asian Pac J Cancer Prev. 2012;13(8):3561-3568. [CrossRef]
29. Ward BK, Magno AL, Walsh JP, Ratajczak T. The role of the calcium-sensing receptor in human disease. Clin Biochem. 2012;45(12):943-953. [CrossRef]
30. Wang F, Yin J, Wang X, et al. Exposure to trichloromethane via drinking water promotes progression of colorectal cancer by activating IRE1alpha/XBP1 pathway of endoplasmic reticulum stress. Sci Total Environ. 2024;949:175040. [CrossRef]
31. Thapa N, Wen T, Cryns VL, Anderson RA. Regulation of cell adhesion and migration via microtubule cytoskeleton organization, cell polarity, and phosphoinositide signaling. Biomolecules. 2023;13(10):1430. [CrossRef]
32. Colella M, Iannucci A, Maresca C, et al. SMAD7 sustains XIAP expression and migration of colorectal carcinoma cells. Cancers (Basel). 2024;16(13):2370. [CrossRef]
33. Mohseni M, Chishti AH. The headpiece domain of dematin regulates cell shape, motility, and wound healing by modulating RhoA activation. Mol Cell Biol. 2008;28(15):4712-4718. [CrossRef]
34. Ye YP, Jiao HL, Wang SY, et al. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation. J Exp Clin Cancer Res. 2018;37(1):299. [CrossRef]